ABS Bio Acquires Cureline, Broadening Access to Biospecimens & Streamlining Execution from End to End
HealthcareCaliforniaAdd-on
ABS Bio→Cureline
Jan 6, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tracking 1 M&A deal by ABS Bio.
ABS Bio→Cureline
Jan 6, 2026